Clinical Trials · NCT06931028
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Enrollment
- 260
- Start date
- Jun 2025
- Locations
- 1 site, China
- Primary endpoint
- Change from Baseline in Apnea-Hypopnea Index (AHI)